loader

tsxv:hem

LATEST ARTICLES
Hemostemix Closes $480,000 Private Placement at $0.12 per Share

Hemostemix Closes $480,000 Private Placement at $0.12 per Share

Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/

Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/

Hemostemix Closes Private Placement of $461,230

Hemostemix Closes Private Placement of $461,230

Hemostemix's Boots on the Ground in Florida October Update

Hemostemix's Boots on the Ground in Florida October Update

Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42

Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol

Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

Hemostemix Files for Ethics Approval of its Study of Vascular Dementia

Hemostemix's Insider Lead Order of $330,000 Private Placement

Hemostemix's Insider Lead Order of $330,000 Private Placement

Hemostemix Files FDA Submission for Basket Protocol to Advance ACP-01 ) Across Multiple Ischemic and Vascular Indications Simultaneously

Hemostemix Files FDA Submission for Basket Protocol to Advance ACP-01 ) Across Multiple Ischemic and Vascular Indications Simultaneously

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES